T-BSDB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem Diabody) |
Human |
|
EGFR |
ZnO |
Inquiry |
SCIGG-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
EGFR |
ZnO |
Inquiry |
FVTIG-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
EGFR |
ZnO |
Inquiry |
BSSG-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
EGFR |
ZnO |
Inquiry |
IGLFV-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
EGFR |
ZnO |
Inquiry |
BSGV-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
EGFR |
ZnO |
Inquiry |
BSDG-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
EGFR |
ZnO |
Inquiry |
BABFV-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
EGFR |
ZnO |
Inquiry |
FABVC-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
EGFR |
ZnO |
Inquiry |
SCDBC-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
EGFR |
ZnO |
Inquiry |
BSDBC-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
EGFR |
ZnO |
Inquiry |
SCDBF-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
EGFR |
ZnO |
Inquiry |
BSFVF-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
EGFR |
ZnO |
Inquiry |
BSDBF-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
EGFR |
ZnO |
Inquiry |
BSTF-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-Fc-scFv |
EGFR |
ZnO |
Inquiry |
BSCFV-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scFv-Fc) |
Human |
scFv-Fc |
EGFR |
ZnO |
Inquiry |
MNAB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Miniantibody) |
Human |
Miniantibody |
EGFR |
ZnO |
Inquiry |
BSFC-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scFv-CH3) |
Human |
scFv-CH3 |
EGFR |
ZnO |
Inquiry |
BSCC-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-CH1/CL |
EGFR |
ZnO |
Inquiry |
BIBD-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Bibody) |
Human |
Bibody |
EGFR |
ZnO |
Inquiry |
FABFV-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
EGFR |
ZnO |
Inquiry |
MiniB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Minibody) |
Human |
Minibody |
EGFR |
ZnO |
Inquiry |
SCDB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
EGFR |
ZnO |
Inquiry |
FABIG-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
EGFR |
ZnO |
Inquiry |
TRIB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Triple Body) |
Human |
Triple Body |
EGFR |
ZnO |
Inquiry |
BSIG-158 |
Anti-EGFR x Anti-ZnO Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
EGFR |
ZnO |
Inquiry |
CROSSAB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (CrossMab) |
Human |
CrossMab |
EGFR |
ZnO |
Inquiry |
IGFV-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
EGFR |
ZnO |
Inquiry |
BSDB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Diabody) |
Human |
Diabody |
EGFR |
ZnO |
Inquiry |
BSFAB-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
EGFR |
ZnO |
Inquiry |
BSFV-158 |
Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
EGFR |
ZnO |
Inquiry |
FABIG-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
EGFR |
HER2 |
Inquiry |
FABIG-154 |
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
EGFR |
MET |
Inquiry |
FABIG-151 |
Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
doxorubicin |
EGFR |
Inquiry |
FABIG-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
EGFR |
Inquiry |
FABIG-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
EGFR |
Inquiry |
FABIG-077 |
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD3 |
EGFR |
Inquiry |
FABIG-058 |
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD28 |
EGFR |
Inquiry |
FABIG-046 |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD2 |
EGFR |
Inquiry |
FABIG-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
EGFR |
Inquiry |
FABIG-031 |
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD133 |
EGFR |
Inquiry |
TRIB-157 |
Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (Triple Body) |
Human |
Triple Body |
EGFR |
IGF1R |
Inquiry |
TRIB-156 |
Recombinant Anti-EGFR x Anti-HER3 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
EGFR |
HER3 |
Inquiry |
TRIB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
EGFR |
HER2 |
Inquiry |
TRIB-154 |
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Triple Body) |
Human |
Triple Body |
EGFR |
MET |
Inquiry |
TRIB-151 |
Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
doxorubicin |
EGFR |
Inquiry |
TRIB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD89 |
EGFR |
Inquiry |
TRIB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
EGFR |
Inquiry |
TRIB-077 |
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD3 |
EGFR |
Inquiry |
TRIB-058 |
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD28 |
EGFR |
Inquiry |
TRIB-046 |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD2 |
EGFR |
Inquiry |
TRIB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
EGFR |
Inquiry |
TRIB-031 |
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD133 |
EGFR |
Inquiry |
BSIG-157 |
Anti-EGFR x Anti-IGF1R Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
EGFR |
IGF1R |
Inquiry |
BSIG-156 |
Anti-EGFR x Anti-HER3 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
EGFR |
HER3 |
Inquiry |
BSIG-155 |
Anti-EGFR x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
EGFR |
HER2 |
Inquiry |
BSIG-154 |
Anti-EGFR x Anti-MET Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
EGFR |
MET |
Inquiry |
BSIG-151 |
Anti-doxorubicin x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
doxorubicin |
EGFR |
Inquiry |
BSIG-132 |
Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
EGFR |
Inquiry |
BSIG-125 |
Anti-CD64 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
EGFR |
Inquiry |
BSIG-077 |
Anti-CD3 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD3 |
EGFR |
Inquiry |
BSIG-058 |
Anti-CD28 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD28 |
EGFR |
Inquiry |
BSIG-046 |
Anti-CD2 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD2 |
EGFR |
Inquiry |
BSIG-036 |
Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
EGFR |
Inquiry |
BSIG-031 |
Anti-CD133 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD133 |
EGFR |
Inquiry |
CROSSAB-157 |
Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (CrossMab) |
Human |
CrossMab |
EGFR |
IGF1R |
Inquiry |
CROSSAB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
EGFR |
HER2 |
Inquiry |
CROSSAB-154 |
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (CrossMab) |
Human |
CrossMab |
EGFR |
MET |
Inquiry |
CROSSAB-151 |
Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
doxorubicin |
EGFR |
Inquiry |
CROSSAB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
EGFR |
Inquiry |
CROSSAB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
EGFR |
Inquiry |
CROSSAB-077 |
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
EGFR |
Inquiry |
CROSSAB-058 |
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD28 |
EGFR |
Inquiry |
CROSSAB-046 |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD2 |
EGFR |
Inquiry |
CROSSAB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
EGFR |
Inquiry |
CROSSAB-031 |
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD133 |
EGFR |
Inquiry |
IGFV-157 |
Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
EGFR |
IGF1R |
Inquiry |
IGFV-156 |
Recombinant Anti-EGFR x Anti-HER3 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
EGFR |
HER3 |
Inquiry |
IGFV-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
EGFR |
HER2 |
Inquiry |
IGFV-154 |
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
EGFR |
MET |
Inquiry |
IGFV-151 |
Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
doxorubicin |
EGFR |
Inquiry |
IGFV-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
EGFR |
Inquiry |
IGFV-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
EGFR |
Inquiry |
IGFV-077 |
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
EGFR |
Inquiry |
IGFV-058 |
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD28 |
EGFR |
Inquiry |
IGFV-046 |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD2 |
EGFR |
Inquiry |
IGFV-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
EGFR |
Inquiry |
IGFV-031 |
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD133 |
EGFR |
Inquiry |
BSDB-157 |
Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (Diabody) |
Human |
Diabody |
EGFR |
IGF1R |
Inquiry |
BSDB-156 |
Recombinant Anti-EGFR x Anti-HER3 Bispecific Antibody (Diabody) |
Human |
Diabody |
EGFR |
HER3 |
Inquiry |
BSDB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
EGFR |
HER2 |
Inquiry |
BSDB-154 |
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Diabody) |
Human |
Diabody |
EGFR |
MET |
Inquiry |
BSDB-151 |
Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
doxorubicin |
EGFR |
Inquiry |
BSDB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
EGFR |
Inquiry |
BSDB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
EGFR |
Inquiry |
BSDB-077 |
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
EGFR |
Inquiry |
BSDB-058 |
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD28 |
EGFR |
Inquiry |
BSDB-046 |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD2 |
EGFR |
Inquiry |
BSDB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
EGFR |
Inquiry |
BSDB-031 |
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD133 |
EGFR |
Inquiry |
BSFV-151 |
Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
doxorubicin |
EGFR |
Inquiry |
BSFAB-157 |
Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
EGFR |
IGF1R |
Inquiry |
BSFAB-156 |
Recombinant Anti-EGFR x Anti-HER3 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
EGFR |
HER3 |
Inquiry |
BSFAB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
EGFR |
HER2 |
Inquiry |
BSFAB-154 |
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
EGFR |
MET |
Inquiry |
BSFAB-151 |
Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
doxorubicin |
EGFR |
Inquiry |
BSFAB-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
EGFR |
Inquiry |
BSFAB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
EGFR |
Inquiry |
BSFAB-077 |
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
EGFR |
Inquiry |
BSFAB-058 |
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD28 |
EGFR |
Inquiry |
BSFAB-046 |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD2 |
EGFR |
Inquiry |
BSFAB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
EGFR |
Inquiry |
BSFAB-031 |
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD133 |
EGFR |
Inquiry |
BSFV-157 |
Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
EGFR |
IGF1R |
Inquiry |
BSFV-156 |
Recombinant Anti-EGFR x Anti-HER3 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
EGFR |
HER3 |
Inquiry |
BSFV-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
EGFR |
HER2 |
Inquiry |
BSFV-154 |
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
EGFR |
MET |
Inquiry |
BSFV-132 |
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
EGFR |
Inquiry |
BSFV-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
EGFR |
Inquiry |
BSFV-077 |
Recombinant Anti-CD3 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
EGFR |
Inquiry |
BSFV-058 |
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD28 |
EGFR |
Inquiry |
BSFV-046 |
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD2 |
EGFR |
Inquiry |
BSFV-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
EGFR |
Inquiry |
BSFV-031 |
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD133 |
EGFR |
Inquiry |